{
    "Trade/Device Name(s)": [
        "ETEST Telavancin",
        "ETEST\u00ae Telavancin"
    ],
    "Submitter Information": "bioM\u00e9rieux SA",
    "510(k) Number": "K180936",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151873"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "April 9, 2018",
    "Summary Letter Received Date": "April 10, 2018",
    "Submission Date": "July 2, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Telavancin"
    ],
    "Specimen Type(s)": [
        "Non-fastidious Gram-negative and Gram-positive aerobic bacteria",
        "fastidious bacteria",
        "Enterobacteriaceae",
        "Pseudomonas",
        "Staphylococcus",
        "Enterococcus",
        "Anaerobes",
        "Neisseria gonorrhoeae",
        "Streptococcus pneumoniae",
        "Streptococcus",
        "Haemophilus species",
        "Staphylococcus aureus (including methicillin resistant isolates)",
        "Enterococcus faecalis (vancomycin susceptible isolates only)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Antibiotic gradient diffusion",
        "Minimum Inhibitory Concentration (MIC) determination"
    ],
    "Methodologies": [
        "Quantitative antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for ETEST Telavancin quantitative antimicrobial susceptibility test for Gram-positive bacteria using predefined antibiotic gradient strips",
    "Indications for Use Summary": "Quantitative technique for determining antimicrobial susceptibility of various aerobic and fastidious bacteria, including Staphylococcus aureus and vancomycin-susceptible Enterococcus faecalis, by MIC determination of telavancin using overnight incubation on agar.",
    "fda_folder": "Microbiology"
}